Narrow Results By
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11297
Bill C-17 An Act to amend the Food and Drugs Act
https://policybase.cma.ca/link/policy11196
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
https://policybase.cma.ca/link/policy11129
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
https://policybase.cma.ca/link/policy11125
The Health risks and harms associated with the use of marijuana
https://policybase.cma.ca/link/policy11138
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use
https://policybase.cma.ca/link/policy14443
- Date
- 2021-06-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Policy endorsement
- Date
- 2021-06-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
Proposed amendments to the marihuana for medical purposes regulations
https://policybase.cma.ca/link/policy11293
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
https://policybase.cma.ca/link/policy11114
Tamper Resistance under the Controlled Drugs and Substances Act
https://policybase.cma.ca/link/policy11295
- Date
- 2014-08-26
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs